Home/Research library/Bock-Marquette et al. (2004)
Animal study · 2004 · cited for TB-500

Thymosin beta4 activates integrin-linked kinase and promotes cardiac cell migration, survival and cardiac repair

Bock-Marquette I, Saxena A, White MD, Dimaio JM, Srivastava D. Nature 2004;432(7016):466-72. doi:10.1038/nature03000 · PubMed 15565145

In brief

This Nature paper connects thymosin beta-4 to heart repair. The peptide, known for sequestering G-actin, promoted migration of myocardial and endothelial cells in the embryonic heart and kept that property in postnatal cardiomyocytes; it also improved the survival of embryonic and postnatal heart cells in culture. Mechanistically, thymosin beta-4 formed a complex with the adaptor protein PINCH and integrin-linked kinase, which activated the survival kinase Akt. In mice whose coronary artery was tied off to produce a heart attack, treatment raised integrin-linked kinase and Akt activity in the heart, improved early survival of heart-muscle cells and improved cardiac function. The authors propose the pathway as a target in acute myocardial damage.

Study design

Mechanistic study in embryonic and postnatal mouse cardiac cells, followed by coronary-artery ligation in mice with thymosin beta-4 treatment.

What it does not show

A mouse infarction model with early endpoints. The finding motivated later clinical work on thymosin beta-4 in cardiac injury, but this paper contains no human data.

Results in rodents or other animals often do not reproduce in people. Species, route, dose and the injury or disease model all shape the outcome, and an effect in a rat is a reason for further study, not a conclusion.

Where this paper is cited

  • TB-500 — Thymosin β4 activated integrin-linked kinase in cardiomyocytes and improved cardiac function after coronary ligation in mice.

Other papers cited for TB-500

Further reading

How this page was made: the citation was retrieved from PubMed by PMID and checked against the title on the product page; the summary was written from the paper's abstract and reports only what the abstract reports. Read the paper itself before relying on any figure here.

Research use only This page summarises a published paper. It is not a claim that any product sold by Zyrna Research does what the paper describes, and nothing here is dosing guidance. Nothing sold by Zyrna Research is for human or veterinary use.